Viking Therapeutics Inc
SWB:1VT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Viking Therapeutics Inc
SWB:1VT
|
US |
|
S
|
Siemens AG
XBER:SIE
|
DE |
|
I
|
Intellia Therapeutics Inc
F:38I
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
XMUN:ME9
|
IT |
|
Align Technology Inc
NASDAQ:ALGN
|
US |
|
R
|
Rusta AB (publ)
STO:RUSTA
|
SE |
|
K
|
Kennametal Inc
XBER:KM3
|
US |
|
BriQ Properties REIC
F:BRW
|
GR |
|
V
|
Vertex Pharmaceuticals Inc
SWB:VX1
|
US |
|
H
|
Healthequity Inc
F:2HE
|
US |
|
O
|
Onyx Gold Corp
XTSX:ONYX
|
CA |
|
H
|
Hyatt Hotels Corp
XMUN:1HTA
|
US |
|
F
|
Fresh Del Monte Produce Inc
DUS:FDM
|
US |
|
Greenyard NV
F:2P1
|
BE |
|
M&G PLC
F:7MP
|
UK |
|
Chemometec A/S
F:CHY
|
DK |
|
F
|
Five9 Inc
SWB:1F9
|
US |
|
Axcelis Technologies Inc
NASDAQ:ACLS
|
US |
Wall St Price Targets
1VT Price Targets Summary
Viking Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
1VT is 80.98 EUR with a low forecast of 29.99 EUR and a high forecast of 111.34 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1VT's stock price target?
Price Target
80.98
EUR
According to Wall Street analysts, the average 1-year price target for
1VT is 80.98 EUR with a low forecast of 29.99 EUR and a high forecast of 111.34 EUR.